Aurinia Pharmaceuticals Inc — Quarterly Cash Flow (NASDAQ:AUPH) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Total assets 549.36 M550.64 M504.85 M502.56 M527.53 M751.59 M Total liabilities 161.36 M173.17 M154.66 M167.26 M161.76 M170.26 M Total equity 388 M377.48 M350.19 M335.3 M365.77 M581.33 M Total liabilities & shareholders' equities 549.36 M550.64 M504.85 M502.56 M527.53 M751.59 M Total debt —————— Net debt ——————

Notizie

Miners Barrick, Pan American Leads 10 Hot Growth Stocks Onto The IBD 50, Other Premium Lists

Drug Stocks Lead Eight Hot New Names Onto IBD 50 List, Big Cap 20 And More

Why Is Aurinia Pharmaceuticals (AUPH) Stock Dropping After Strong Quarter? - Aurinia Pharmaceuticals (NASDAQ:AUPH)

Aurinia Pharma earnings beat by $1.38, revenue topped estimates

Risultati Aurinia in arrivo: il farmaco per il lupus può mantenere lo slancio?

United Therapeutics (UTHR) Surpasses Q4 Earnings Estimates

Xenon Pharmaceuticals Stock Scores RS Rating Upgrade

CRISPR Therapeutics Stock Sees RS Rating Rise To 73

Neurocrine Biosciences (NBIX) Lags Q4 Earnings Estimates

AI Standout Broadcom Earns Spot In Sector Leaders, Leads 16 Onto Best Stock Lists

Aerospace/Defense Play Karmen Leads 19 To Best Stock Lists Including IBD 50, Stock Spotlight

This Pharma Stock With Earnings Seen Soaring 1,854% Forms Bullish Base